1443792-51-5

Basic information

• Product Name: 5-Bromo-2-iodo-4-methoxypyrimidine
• Synonyms: 5-Bromo-2-iodo-4-methoxypyrimidine
• CAS NO: 1443792-51-5
• Molecular Formula: C5H4BrIN2O
• Molecular Weight: 314.908
• Mol File: 1443792-51-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 5-Bromo-2-iodo-4-methoxypyrimidine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Bromo-2-iodo-4-methoxypyrimidine(1443792-51-5)
• EPA Substance Registry System: 5-Bromo-2-iodo-4-methoxypyrimidine(1443792-51-5)

Safety Data

• Hazardous Substances Data: 1443792-51-5(Hazardous Substances Data)

Upstream product

• 57054-92-9 5-bromo-2-chloro-4-methoxypyrimidine 

Downstream Products

• 1443792-53-7 tert-butyl (S)-2-(4-(tert-butyl)benzamido)-3-(4-(5-(4-(heptyloxy)phenyl)-4-methoxypyrimidin-2-yl)phenyl)propanoate 
• 1443790-93-9 (S)-2-(4-(tert-butyl)benzamido)-3-(4-(5-(4-(heptyloxy)phenyl)-4-methoxypyrimidin-2-yl)phenyl)propanoic acid 
• 1443792-52-6 tert-butyl (S)-3-(4-(5-bromo-4-methoxypyrimidin-2-yl)phenyl)-2-(4-(tert-butyl)benzamido)propanoate 

Relevant articles and documents

GLP-1 RECEPTOR MODULATORS

Compounds are provided that modulate the glucagon-like peptide 1 (GLP-1) receptor, as well as methods of their synthesis, and methods of their therapeutic and/or prophylactic use. Such compounds can act as modulators or potentiators of GLP-1 receptor on their own, or with incretin peptides such as GLP-1(7-36) and GLP-1(9-36), or with peptide-based therapies, such as exenatide and liraglutide, and have the following general structure (where "^^^^" represents either or both the R and S form of the compound) (I) where A, B, C, Y1, Y2, Z, R1, R2, R3, R4, R5, W1, n, p and q are as defined herein.